HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristina Viktorsson Selected Research

Neoplasm Metastasis (Metastasis)

1/2022Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial.
10/2013miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristina Viktorsson Research Topics

Disease

23Neoplasms (Cancer)
07/2023 - 01/2005
19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2023 - 10/2003
5Lung Neoplasms (Lung Cancer)
07/2023 - 06/2005
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2022 - 01/2005
5Carcinoma (Carcinomatosis)
10/2022 - 07/2013
4Pleural Effusion (Pleural Effusions)
12/2021 - 10/2018
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022 - 06/2009
3Melanoma (Melanoma, Malignant)
01/2022 - 05/2002
3Adenocarcinoma
11/2021 - 10/2018
2Neuroblastoma
11/2022 - 09/2007
2Neoplasm Metastasis (Metastasis)
01/2022 - 10/2013
2Tics (Tic)
01/2018 - 08/2014
2Leukemia
06/2009 - 01/2005
1Hypoxia (Hypoxemia)
12/2023
1Prostatic Neoplasms (Prostate Cancer)
01/2023
1Disease Progression
01/2023
1Virus Diseases (Viral Diseases)
11/2022
1Autoimmune Diseases (Autoimmune Disease)
11/2022
1Malignant Pleural Effusion
11/2022
1Lung Diseases (Lung Disease)
10/2018
1Adenocarcinoma of Lung
10/2018
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2018
1Glioblastoma (Glioblastoma Multiforme)
12/2017
1Glioma (Gliomas)
12/2017
1Ovarian Neoplasms (Ovarian Cancer)
09/2016
1Peritoneal Neoplasms
09/2016

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
07/2023 - 10/2013
6Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2013
6Cisplatin (Platino)FDA LinkGeneric
01/2018 - 05/2002
5DNA (Deoxyribonucleic Acid)IBA
02/2021 - 08/2007
4Phosphotransferases (Kinase)IBA
10/2022 - 10/2003
4PlatinumIBA
04/2020 - 09/2015
3ErbB Receptors (EGF Receptor)IBA
07/2023 - 01/2019
3Tyrosine Kinase InhibitorsIBA
07/2023 - 09/2021
3melflufenIBA
09/2016 - 06/2013
2NucleotidesIBA
11/2022 - 11/2022
2EnzymesIBA
11/2022 - 06/2013
2Membrane Proteins (Integral Membrane Proteins)IBA
11/2022 - 09/2021
2RNA (Ribonucleic Acid)IBA
10/2022 - 10/2018
2Gemtuzumab (Mylotarg)FDA Link
06/2022 - 06/2009
2EphrinsIBA
02/2021 - 05/2011
2Eph Family Receptors (Eph Receptors)IBA
02/2021 - 09/2016
2MicroRNAs (MicroRNA)IBA
10/2018 - 10/2013
2Small Interfering RNA (siRNA)IBA
01/2018 - 06/2013
2Bleomycin (Blenoxane)FDA LinkGeneric
12/2017 - 08/2007
2Alkylating AgentsIBA
09/2016 - 06/2013
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2014 - 10/2008
2ProdrugsIBA
06/2013 - 09/2007
2Melphalan (Alkeran)FDA LinkGeneric
06/2013 - 09/2007
1Cell Adhesion MoleculesIBA
12/2023
1human ERBB2 proteinIBA
07/2023
1B7-H1 AntigenIBA
07/2023
1TetraspaninsIBA
07/2023
1Tumor Biomarkers (Tumor Markers)IBA
07/2023
1Cytidine DeaminaseIBA
11/2022
1CytidineIBA
11/2022
1UridineIBA
11/2022
1pyrimidineIBA
11/2022
1RibonucleotidesIBA
11/2022
1Dihydroorotate DehydrogenaseIBA
11/2022
1osimertinibIBA
10/2022
1Tyrosine (L-Tyrosine)FDA Link
10/2022
1Caspase 2IBA
06/2022
1AlkanesIBA
04/2022
1Immune Checkpoint InhibitorsIBA
11/2021
1ErythropoietinFDA Link
02/2021
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
02/2021
1Circulating Tumor DNAIBA
02/2021
1Histone Deacetylases (Histone Deacetylase)IBA
01/2018
1Histones (Histone)IBA
01/2018
1Lysine (L-Lysine)FDA Link
01/2018
1ChromatinIBA
01/2018
1VorinostatFDA Link
01/2018
1EuchromatinIBA
01/2018
1DNA-Activated Protein KinaseIBA
01/2018
1trichostatin A (A 300)IBA
01/2018
1HeterochromatinIBA
01/2018
1Temozolomide (Temodar)FDA LinkGeneric
12/2017
1Ephrin-B3 (Ephrin B3)IBA
09/2016
1Ephrin-A1 (Ephrin A1)IBA
09/2016
1liposomal doxorubicin (Doxil)FDA Link
09/2016
1GemcitabineFDA Link
09/2016
1Peptide Hydrolases (Proteases)FDA Link
09/2016
1AlcoholsIBA
08/2016
1Insulin ReceptorIBA
08/2016
1AcetyleneIBA
08/2016
1Somatomedin Receptors (Somatomedin Receptor)IBA
08/2016
1Dasatinib (BMS 354825)FDA Link
01/2016
1Platinum Compounds (Compounds, Platinum)IBA
09/2015
1Alkynes (Acetylenes)IBA
12/2014
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2014
1STAT1 Transcription FactorIBA
08/2014
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2014

Therapy/Procedure

9Drug Therapy (Chemotherapy)
12/2021 - 06/2005
8Therapeutics
12/2023 - 01/2005
2Radiotherapy
12/2017 - 06/2005
1Immunotherapy
01/2023
1Aftercare (After-Treatment)
09/2021
1Cytoreduction Surgical Procedures
09/2016
1Cystectomy
11/2014